Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the ...

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

While non-exhaustive, this list offers an overview of the year’s biotech events taking place around the world, aimed at partnering and connecting with decision makers in biopharma. If there is a ...

AI has completely shifted the paradigm in the biotech industry. The past year has seen a gold rush in AI applications for the biopharma sector, for drug and protein discovery, or even treatment ...

2023 marked a significant milestone in Alzheimer’s disease (AD) treatment with the FDA’s approval of LEQEMBI (lecanemab-irmb). This groundbreaking treatment, developed by Eisai Co., Ltd. and Biogen ...